1. Home
  2. GPOR vs MIRM Comparison

GPOR vs MIRM Comparison

Compare GPOR & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPOR
  • MIRM
  • Stock Information
  • Founded
  • GPOR 1997
  • MIRM 2018
  • Country
  • GPOR United States
  • MIRM United States
  • Employees
  • GPOR N/A
  • MIRM N/A
  • Industry
  • GPOR Oil & Gas Production
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • GPOR Energy
  • MIRM Health Care
  • Exchange
  • GPOR Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • GPOR 3.4B
  • MIRM 2.5B
  • IPO Year
  • GPOR N/A
  • MIRM 2019
  • Fundamental
  • Price
  • GPOR $185.93
  • MIRM $50.30
  • Analyst Decision
  • GPOR Strong Buy
  • MIRM Strong Buy
  • Analyst Count
  • GPOR 8
  • MIRM 9
  • Target Price
  • GPOR $216.88
  • MIRM $66.22
  • AVG Volume (30 Days)
  • GPOR 264.4K
  • MIRM 468.1K
  • Earning Date
  • GPOR 08-05-2025
  • MIRM 08-06-2025
  • Dividend Yield
  • GPOR N/A
  • MIRM N/A
  • EPS Growth
  • GPOR N/A
  • MIRM N/A
  • EPS
  • GPOR N/A
  • MIRM N/A
  • Revenue
  • GPOR $1,014,317,000.00
  • MIRM $379,251,000.00
  • Revenue This Year
  • GPOR $56.18
  • MIRM $35.83
  • Revenue Next Year
  • GPOR $13.45
  • MIRM $16.83
  • P/E Ratio
  • GPOR N/A
  • MIRM N/A
  • Revenue Growth
  • GPOR 11.01
  • MIRM 69.31
  • 52 Week Low
  • GPOR $130.02
  • MIRM $33.52
  • 52 Week High
  • GPOR $210.32
  • MIRM $54.23
  • Technical
  • Relative Strength Index (RSI)
  • GPOR 39.43
  • MIRM 59.09
  • Support Level
  • GPOR $184.13
  • MIRM $47.89
  • Resistance Level
  • GPOR $206.29
  • MIRM $51.93
  • Average True Range (ATR)
  • GPOR 6.16
  • MIRM 1.49
  • MACD
  • GPOR -2.09
  • MIRM -0.25
  • Stochastic Oscillator
  • GPOR 6.87
  • MIRM 59.65

About GPOR Gulfport Energy Corporation

Gulfport Energy Corp is an independent natural gas-weighted exploration and production company focused on the exploration, acquisition, and production of natural gas, crude oil, and natural gas liquids, with assets predominantly located in the Appalachia and Anadarko basins in the United States. Its principal properties are located in eastern Ohio, targeting the Utica and Marcellus, and in central Oklahoma, targeting the SCOOP Woodford and Springer formations.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: